United States
Germany
Japan
United Kingdom
China
IL12A goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Canine, Human, Porcine, Monkey |
Antibodies
Monkey IgG (H+L chain) goat polyclonal antibody, Azide Free
| Applications | As unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Recommended working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/5000. |
| Reactivities | Monkey |
| Conjugation | Unconjugated |
Monkey IgG (Fc specific) goat polyclonal antibody, TRITC
| Applications | Can be used for direct immunofluorescence staining of cytoplasmic Ig of appropriately treated cell and tissue substrates; to demonstrate immunoglobulins or specific antibodies in cells and tissues; to identify circulating antibodies in serodiagnostic microbiology and autoimmune diseases. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/10 and 1/30. |
| Reactivities | Monkey |
| Conjugation | TRITC |
Monkey IgM (Fc specific) goat polyclonal antibody, TRITC
| Applications | Can be used for direct immunofluorescence staining of cytoplasmic IgM of appropriately treated cell and tissue substrates; to demonstrate immunoglobulins or specific antibodies in cells and tissues; to identify circulating antibodies in serodiagnostic microbiology and autoimmune diseases. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/10 and 1/40. |
| Reactivities | Monkey |
| Conjugation | TRITC |
Monkey IgA + IgG + IgM (H+L chain) goat polyclonal antibody, TRITC
| Applications | Can be used for direct immunofluorescence staining of cytoplasmic Ig of appropriately treated cell and tissue substrates; to demonstrate immunoglobulins or specific antibodies in cells and tissues; to identify circulating antibodies in serodiagnostic microbiology and autoimmune diseases. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/10 and 1/40. |
| Reactivities | Monkey |
| Conjugation | TRITC |
Monkey IgA (Fc specific) goat polyclonal antibody, TRITC
| Applications | Can be used for direct immunofluorescence staining of cytoplasmic Ig of appropriately treated cell and tissue substrates; to demonstrate immunoglobulins or specific antibodies in cells and tissues; to identify circulating antibodies in serodiagnostic microbiology and autoimmune diseases. Antisera to IgA do not discriminate between serum IgA (monomeric and dimeric) and higher molecular forms such as secretory IgA. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions are usually between 1/10 and 1/30. |
| Reactivities | Monkey |
| Conjugation | TRITC |
Axin 1 (AXIN1) (850-862) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat, Canine, Bovine, Bat, Equine, Hamster, Monkey, Zebrafish |
Human IgE goat polyclonal antibody, AP
| Applications | ELISA: 1/1000-1/10000. Western Blot: 1/1000-1/5000. |
| Reactivities | Human, Monkey |
| Conjugation | AP |
Human IgE goat polyclonal antibody, FITC
| Applications | Flow Cytometry. |
| Reactivities | Human, Monkey |
| Conjugation | FITC |
Goat Polyclonal Anti-REP1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
Monkey IgM (Fc specific) goat polyclonal antibody, Azide Free
| Applications | As unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Recommended Working Dilutions: In Histochemistry are usually between 1/100 and 1/500. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/5000. |
| Reactivities | Monkey |
| Conjugation | Unconjugated |
Monkey IgA (Fc specific) goat polyclonal antibody, Azide Free
| Applications | Can be used as unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. Antisera to IgA do not discriminate between serum IgA (monomeric and dimeric) and higher molecular forms such as secretory IgA. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Recommended working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/2500. |
| Reactivities | Monkey |
| Conjugation | Unconjugated |
Monkey IgA + IgG + IgM (Fc specific) goat polyclonal antibody, Azide Free
| Applications | The cytochemical grade allows the use in different types of highly sensitive immunoassays on appropriately treated cell and tissue substrates; in radioimmunoassay; for the production of immunoconjugates with a selected marker; to prepare immunoaffinity adsorbents by coupling to an artificial carrier; in non-isotopic methodology based on solid phase immunochemistry (e.g. ELISA), both as catching antibody and detection reagent; in Western blotting. This product is not pre-diluted. The optimum working dilution of each product should be established by titration before being used. Working dilutions: For histochemical and cytochemical use are usually between 1/100 and 1/500. In ELISA and comparable non-precipitating antibody-binding assays are between 1/1000 and 1/5000. |
| Reactivities | Monkey |
| Conjugation | Unconjugated |
Monkey IgA + IgG + IgM (H+L chain) goat polyclonal antibody, Azide Free
| Applications | This IgG fraction allows the use in different types of highly sensitive immunoassays on appropriately treated cell and tissue substrates; in radioimmunoassay; for the production of immunoconjugates with a selected marker; to prepare immunoaffinity adsorbents by coupling to an artificial carrier; in non-isotopic methodology based on solid phase immunochemistry (e.g. ELISA), both as catching antibody and detection reagent; in Western blotting. This product is not pre-diluted. The optimum working dilution of each product should be established by titration before being used. Working dilutions: For histochemical and cytochemical use are usually between 1/100 and 1/500. In ELISA and comparable non-precipitating antibody-binding assays are between 1/1000 and 1/5000. |
| Reactivities | Monkey |
| Conjugation | Unconjugated |
C3 goat polyclonal antibody, Azide Free
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Monkey |
活动过滤器
优化搜索结果
Target Symbol
- RAB27A (5)
- ATAXIN 3 (4)
- C3 (4)
- CALNEXIN (4)
- CHM (4)
- ERP57 (4)
- LACTOFERRIN (4)
- ALPHA TUBULIN (3)
- GAPDH (3)
- GJA1 (3)
- RAB11A (3)
- RAB5 (3)
- CATHEPSIN D (2)
- CD19 (2)
- CD45 (2)
- CD63 (2)
- E CADHERIN (2)
- FMRP (2)
- GFAP (2)
- P53 (2)
- RAB14 (2)
- RAB1B (2)
- RAB35 (2)
- RAB9A (2)
- ACTIVIN RECEPTOR TYPE IA (1)
- AIF1 (1)
- ALBUMIN (1)
- ANKYRIN G (1)
- ANNEXIN A1 (1)
- APG12 (1)
- ARSB (1)
- AXIN1 (1)
- BAX (1)
- BETA ACTIN (1)
- BETA CATENIN (1)
- BLBP (1)
- BMI1 (1)
- C-PEPTIDE (1)
- CATALASE (1)
- CD2 (1)
- CD31 (1)
- CD4 (1)
- CD90 (1)
- CLATHRIN HEAVY CHAIN (1)
- CLEC2D (1)
- CLUSTERIN (1)
- CMA1 (1)
- CYTOCHROME P450 26B (1)
- DAP12 (1)
- DKK1 (1)
- EEA1 (1)
- EGFR (1)
- ERG (1)
- ESA1 (1)
- FAAH1 (1)
- FANCG (1)
- FBP17 (1)
- FERRITIN HEAVY CHAIN (1)
- FH (1)
- FOXA2 (1)
- FOXO3 (1)
- FTCD (1)
- GABA B RECEPTOR 1 (1)
- GAD65 (1)
- GAMMA SYNUCLEIN (1)
- GATA3 (1)
- GBX2 (1)
- GLUTATHIONE PEROXIDASE 3 (1)
- GLUTATHIONE PEROXIDASE 4 (1)
- GNAT3 (1)
- GRIA4 (1)
- HC (1)
- HER2 (1)
- HNF 4 ALPHA (1)
- IGFBP6 (1)
- IL10 (1)
- IL12A (1)
- INSULIN (1)
- INSULIN RECEPTOR (1)
- IRAK4 (1)
- ITPR2 (1)
- KMT2B (1)
- LAMIN A (1)
- LIS1 (1)
- MIF (1)
- MONOAMINE OXIDASE B (1)
- MTLRP (1)
- MYH (1)
- N CADHERIN (1)
- NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 (1)
- NOTCH3 (1)
- NUCLEOLIN (1)
- ORP1 (1)
- PANCREATIC POLYPEPTIDE (1)
- PC (1)
- PCK1 (1)
- PDE11A (1)
- PEPSIN (1)
- PERILIPIN-1 (1)
- PEROXIREDOXIN 1 (1)
Isotypes
Clonalities
Assay Types
Families
- Druggable Genome (136)
- Transmembrane (38)
- ES Cell Differentiation/IPS (22)
- Secreted Protein (20)
- Transcription Factors (19)
- Protease (8)
- Protein Kinase (5)
- Stem cell - Pluripotency (4)
- Adult stem cells (3)
- Ion Channels: Other (3)
- Induced pluripotent stem cells (2)
- Ion Channels: Transient receptor potential (2)
- Nuclear Hormone Receptor (2)
- Phosphatase (2)
- Stem cell relevant signaling - JAK/STAT signaling pathway (2)
- Cancer stem cells (1)
- Embryonic stem cells (1)
- GPCR (1)
- Ion Channels: Cys-loop Receptors (1)
- P450 (1)
Pathways
- Endocytosis (14)
- Pathways in cancer (12)
- Metabolic pathways (10)
- Antigen processing and presentation (9)
- Gap junction (9)
- Adherens junction (8)
- Amyotrophic lateral sclerosis (ALS) (8)
- Bladder cancer (8)
- Cell adhesion molecules (CAMs) (8)
- Endometrial cancer (8)
- Pathogenic Escherichia coli infection (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (7)
- Focal adhesion (7)
- Cytokine-cytokine receptor interaction (6)
- Prostate cancer (6)
- T cell receptor signaling pathway (6)
- Alzheimer's disease (5)
- Apoptosis (5)
- Calcium signaling pathway (5)
- Colorectal cancer (5)
- Hematopoietic cell lineage (5)
- Huntington's disease (5)
- Insulin signaling pathway (5)
- Leukocyte transendothelial migration (5)
- Lysosome (5)
- Melanoma (5)
- Neurotrophin signaling pathway (5)
- Non-small cell lung cancer (5)
- Pancreatic cancer (5)
- Primary immunodeficiency (5)
- Thyroid cancer (5)
- Wnt signaling pathway (5)
- Basal cell carcinoma (4)
- Glycolysis / Gluconeogenesis (4)
- MAPK signaling pathway (4)
- PPAR signaling pathway (4)
- Regulation of actin cytoskeleton (4)
- Type I diabetes mellitus (4)
- p53 signaling pathway (4)
- Allograft rejection (3)
- B cell receptor signaling pathway (3)
- Dilated cardiomyopathy (3)
- Fc gamma R-mediated phagocytosis (3)
- Glioma (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Maturity onset diabetes of the young (3)
- Natural killer cell mediated cytotoxicity (3)
- RIG-I-like receptor signaling pathway (3)
- Ribosome (3)
- TGF-beta signaling pathway (3)
- Tight junction (3)
- Toll-like receptor signaling pathway (3)
- Type II diabetes mellitus (3)
- mTOR signaling pathway (3)
- Adipocytokine signaling pathway (2)
- Arachidonic acid metabolism (2)
- Asthma (2)
- Cell cycle (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Citrate cycle (TCA cycle) (2)
- Epithelial cell signaling in Helicobacter pylori infection (2)
- ErbB signaling pathway (2)
- Fc epsilon RI signaling pathway (2)
- Glutathione metabolism (2)
- GnRH signaling pathway (2)
- Histidine metabolism (2)
- Jak-STAT signaling pathway (2)
- Melanogenesis (2)
- NOD-like receptor signaling pathway (2)
- Oocyte meiosis (2)
- Regulation of autophagy (2)
- Renal cell carcinoma (2)
- Small cell lung cancer (2)
- Systemic lupus erythematosus (2)
- Tryptophan metabolism (2)
- Vibrio cholerae infection (2)
- Acute myeloid leukemia (1)
- Alanine (1)
- Androgen and estrogen metabolism (1)
- Arginine and proline metabolism (1)
- Autoimmune thyroid disease (1)
- Axon guidance (1)
- Base excision repair (1)
- Butanoate metabolism (1)
- Dorso-ventral axis formation (1)
- Drug metabolism - cytochrome P450 (1)
- ECM-receptor interaction (1)
- Ether lipid metabolism (1)
- Glycine (1)
- Graft-versus-host disease (1)
- Hedgehog signaling pathway (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Methane metabolism (1)
- Neuroactive ligand-receptor interaction (1)
- One carbon pool by folate (1)
- Parkinson's disease (1)
- Phenylalanine metabolism (1)
- Phosphatidylinositol signaling system (1)
- Porphyrin and chlorophyll metabolism (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Proteasome (1)
- Pyrimidine metabolism (1)
- Pyruvate metabolism (1)
- Renin-angiotensin system (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Taste transduction (1)
- Taurine and hypotaurine metabolism (1)
- Tyrosine metabolism (1)
- Ubiquitin mediated proteolysis (1)
- VEGF signaling pathway (1)
- Vascular smooth muscle contraction (1)
- Viral myocarditis (1)
- aspartate and glutamate metabolism (1)
- beta-Alanine metabolism (1)
- serine and threonine metabolism (1)
